Figure 1.
Downregulation of miR-150-5p in AS joint capsules and fibroblasts. (A) miR-150-5p expression in joint capsule tissues obtained from AS patients and non-AS controls (n=20/group) was determined by reverse transcription-quantitative PCR. (B) miR-150-5p expression in BMP-2 and TGF-β1-treated AS fibroblasts and untreated cells. Data are presented as the mean ± SD. **P<0.01 vs. control. miR, microRNA; AS, ankylosing spondylitis; BMP, bone morphogenetic protein; TGF, transforming growth factor.
